On June 6, 2024, Oramed Pharmaceuticals Inc. appointed Mr. Avraham Gabay to serve as Treasurer and Secretary of the Company, effective as of June 18, 2024. Prior to his appointment, Mr. Gabay served as interim chief financial officer of BiomX Inc. since 2023. From 2021 until 2023, Mr. Gabay served as the chief financial officer at Oravax Inc., a 63% owned subsidiary of the Company.

From 2019 until 2021, Mr. Gabay was the chief financial officer of the Company. From 2015 to 2019, Mr. Gabay served as VP Finance at Orcam Technologies Ltd. From 2014 to 2015, Mr. Gabay provided economic services in the advisory department of KPMG Israel, a certified public accounting firm, and from 2013 to 2014, he worked in the tax department of the law firm Gornitzky & Co. In addition, Mr. Gabay serves as a director on the board of Iintoo Ltd. Mr. Gabay holds a bachelor?s degree in law and accounting (magna cum-laude) from Tel-Aviv University and is a certified public accountant in Israel and a member of the Israeli Bar Association.